Dexlansoprazole Capsules
Designed to mitigate stomach acid production; indicated to alleviate symptoms of acid reflux and support oesophageal healing.
Strengths: 30 · 60mg
Where to Check Availability
Medicine details
- Alternative names
Dexilant
- Therapeutic class
Proton Pump Inhibitor
- Pharmacological class
Proton Pump Inhibitor
- Contraindications
hypersensitivity to proton pump inhibitors
- Precautions and warnings
risk of fractures with long-term use; monitor for hypomagnesaemia
- Minor side effects
diarrhoea; abdominal pain; nausea
- Moderate side effects
flatulence; upper respiratory tract infection
- Dosage forms
Modified-release capsule, hard
- Administration route
Oral use
- Prescription status
POM
- Manufacturer
Takeda
- Onset Time
1–2 hours
- Duration
24 hours
- Storage instructions
Store below 25°C.
- Drug interactions
clopidogrel; methotrexate
- Age restrictions
Not for paediatric use.
- Pregnancy and breastfeeding
Pregnancy: caution advised. Breastfeeding: not recommended.
Serious side effects
clostridium difficile infection — requires immediate medical attention; interstitial nephritis — requires immediate medical attention
Patient summary
Designed to mitigate stomach acid production; indicated to alleviate symptoms of acid reflux and support oesophageal healing.
Mechanism of action
A dual-delayed release proton pump inhibitor. It inhibits the H+/K+-ATPase enzyme system in the gastric parietal cell, suppressing both basal and stimulated gastric acid secretion.
Dexlansoprazole Capsules
Designed to mitigate stomach acid production; indicated to alleviate symptoms of acid reflux and support oesophageal healing.
Editorial Notes
- Active ingredient(s): Dexlansoprazole
- Listed indication(s): Gastro-oesophageal Reflux Disease, Erosive Oesophagitis
Usually available as
- 90 tablets - 30 mg1369-30-mg-16416
- 60 tablets - 60 mg1369-60-mg-16421